[Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza]

Rev Esp Quimioter. 2006 Dec;19(4):317-22.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Acids, Carbocyclic
  • Amino Acid Substitution
  • Animals
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Binding Sites / drug effects
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Cyclopentanes / chemistry
  • Cyclopentanes / pharmacology
  • Cyclopentanes / therapeutic use*
  • Drug Evaluation, Preclinical
  • Drug Resistance, Multiple, Viral / genetics
  • Drug Resistance, Viral / genetics
  • Guanidines / chemistry
  • Guanidines / pharmacology
  • Guanidines / therapeutic use*
  • Humans
  • Influenza A virus / drug effects
  • Influenza A virus / enzymology
  • Influenza A virus / genetics
  • Influenza B virus / drug effects
  • Influenza B virus / enzymology
  • Influenza B virus / genetics
  • Influenza, Human / drug therapy*
  • Mice
  • Molecular Structure
  • Neuraminidase / antagonists & inhibitors*
  • Neuraminidase / genetics
  • Orthomyxoviridae / drug effects*
  • Orthomyxoviridae / enzymology
  • Orthomyxoviridae / genetics
  • Oseltamivir / pharmacology
  • Oseltamivir / therapeutic use
  • Point Mutation
  • Viral Proteins / antagonists & inhibitors*
  • Viral Proteins / genetics

Substances

  • Acids, Carbocyclic
  • Antiviral Agents
  • Cyclopentanes
  • Guanidines
  • Viral Proteins
  • Oseltamivir
  • Neuraminidase
  • peramivir